Exosome-Based Therapeutics in Alzheimer’s Disease: Translational Perspectives Beyond Conventional Therapies
Alzheimer’s disease (AD) remains a major neurodegenerative disorder lacking effective long-term disease-modifying therapies. Current pharmacological approaches provide primarily symptomatic benefit, while recently approved anti-amyloid monoclonal antibodies offer only modest clinical efficacy and are constrained by saf...